JP Morgan Chase
MD icon

JP Morgan Chase’s Pediatrix Medical MD Stock Holding History

JP Morgan Chase’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-36,000
Closed -$2.4M – 5157
2016
Q4 		$2.4M Hold
36,000
– – ﹤0.01% 2951
2016
Q3 		$2.38M Buy
+36,000
New +$2.46M ﹤0.01% 2695

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

JP Morgan Chase's MD Position: Q2 2026 in Review

JP Morgan Chase reduced its Pediatrix Medical (MD) stake by 9.9% in Q2 2026, selling an estimated $525K and leaving 209,894 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3405.

JP Morgan Chase first reported a position in MD in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.9M in Q1 2018. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • JP Morgan Chase held 209,894 shares of Pediatrix Medical worth $5.27M as of Q2 2026.
  • JP Morgan Chase sold 23,061 Pediatrix Medical shares in Q2 2026, an estimated $525K.
  • Pediatrix Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3405 holding.
  • JP Morgan Chase first reported a position in Pediatrix Medical in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Pediatrix Medical position peaked at $35.9M in Q1 2018.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.